ARCHIVES

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

This article is from The Cancer Letter archive.

Vol. 10 No. 05 | February 3, 1984

Download PDF Visit The Full Archive

Related Articles

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

President Requests Extra $200 Million For NIH

March 7, 2014

Coulter And Venture Capital Firm Form Company To Develop B1 Antibody For NHL

April 28, 1995

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

NCAB Committee To Propose Event Marking Cancer Act

August 2, 1991

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992